David Sidransky Insider Profile
4 Followers
David Sidransky, Director at Champions Oncology, holds 0.00 shares in Ayala Pharmaceuticals (Ticker: AYLA), holds 139.00 shares in Advaxis (Ticker: ADXS), holds 767.04K shares in Champions Oncology (Ticker: CSBR).
David Sidransky's Trading History
| ADXSAdvaxis | Jan 23, 2023 | ― | Uninformative Buy | ― | $83.82 | |
| AYLAAyala Pharmaceuticals | Jan 23, 2023 | ― | Uninformative Sell | ― | $0.00 | |
| CSBRChampions Oncology | Oct 14, 2022 | Director | Uninformative Buy | 15.31K | $3.61M | |
| ORGSOrgenesis | Jan 11, 2021 | Director | Informative Buy | 1.07K | $67.50 | |
| IMNPQImmune Pharmaceuticals | Jan 12, 2015 | ― | Uninformative Buy | ― | $216.99 | |
| AKTXAkari Therapeutics | Jan 02, 2015 | Director | Uninformative Buy | ― | $372.18K |
You May Also Like
David Sidransky insider profile FAQ
What is the percentage of profitable transactions made by David Sidransky?
The percentage of profitable transactions made by David Sidransky is 25%.
What is the average return per transaction made by David Sidransky?
The average return per transaction made by David Sidransky is -32.30%.
What stocks does David Sidransky hold?
David Sidransky holds: CSBR, AKTX, ORGS, AYLA, ADXS, IMNPQ stocks.
What was David Sidransky's most profitable transaction?
David Sidransky’s most profitable transaction was an Informative Sell of ADXS stock on August 10, 2016. The return on the trade was 58.90%.
What is David Sidransky's role in Champions Oncology?
David Sidransky's role in Champions Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
